Amrep Cash & Equivalents Growth & History (AXR)
Amrep's cash and equivalents was $52.3M for fiscal 2026.
View full Amrep company overviewAmrep annual cash and equivalents history
| Fiscal year | Period ended | Cash and equivalents | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-30 | $52.3M | $12.9M | +32.59% |
| 2025 | 2025-04-30 | $39.5M | $9.8M | +32.91% |
| 2024 | 2024-04-30 | $29.7M | $9.7M | +48.52% |
| 2023 | 2023-04-30 | $20.0M | $4.3M | +27.17% |
| 2022 | 2022-04-30 | $15.7M | −$9.1M | −36.61% |
| 2021 | 2021-04-30 | $24.8M | $7.3M | +41.70% |
| 2020 | 2020-04-30 | $17.5M | $4.2M | +31.92% |
| 2019 | 2019-04-30 | $13.3M | $2.4M | +22.27% |
| 2018 | 2018-04-30 | $10.9M | −$960,000 | −8.13% |
| 2017 | 2017-04-30 | $11.8M | −$2.8M | −18.89% |
| 2016 | 2016-04-30 | $14.6M | $2.5M | +20.85% |
| 2015 | 2015-04-30 | $12.1M | $4.5M | +59.16% |
| 2014 | 2014-04-30 | $7.6M | $5.0M | +194.94% |
| 2013 | 2013-04-30 | $2.6M | −$25.3M | −90.78% |
| 2012 | 2012-04-30 | $27.8M | $2.1M | +8.12% |
| 2011 | 2011-04-30 | $25.8M | $225,000 | +0.88% |
| 2010 | 2010-04-30 | $25.5M | — | — |
Amrep quarterly cash and equivalents
| Fiscal quarter | Period ended | Cash and equivalents | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-04-30 | $52.3M | $12.9M | +32.59% |
| Q3 2026 | 2026-01-31 | $50.0M | $13.1M | +35.36% |
| Q2 2026 | 2025-10-31 | $44.6M | $4.5M | +11.33% |
| Q1 2026 | 2025-07-31 | $48.9M | $8.6M | +21.28% |
| Q4 2025 | 2025-04-30 | $39.5M | $9.8M | +32.91% |
| Q3 2025 | 2025-01-31 | $36.9M | $18.9M | +105.05% |
| Q2 2025 | 2024-10-31 | $40.1M | $23.4M | +139.70% |
| Q1 2025 | 2024-07-31 | $40.4M | $18.6M | +85.29% |
| Q4 2024 | 2024-04-30 | $29.7M | $9.7M | +48.52% |
| Q3 2024 | 2024-01-31 | $18.0M | $5.6M | +45.23% |
| Q2 2024 | 2023-10-31 | $16.7M | $3.8M | +29.74% |
| Q1 2024 | 2023-07-31 | $21.8M | $5.9M | +36.83% |
| Q4 2023 | 2023-04-30 | $20.0M | $4.3M | +27.17% |
| Q3 2023 | 2023-01-31 | $12.4M | −$14.9M | −54.57% |
| Q2 2023 | 2022-10-31 | $12.9M | −$17.4M | −57.50% |
| Q1 2023 | 2022-07-31 | $15.9M | −$7.4M | −31.62% |
| Q4 2022 | 2022-04-30 | $15.7M | −$9.1M | −36.61% |
| Q3 2022 | 2022-01-31 | $27.3M | $11.9M | +77.20% |
| Q2 2022 | 2021-10-31 | $30.3M | $14.6M | +93.26% |
| Q1 2022 | 2021-07-31 | $23.3M | $6.2M | +36.36% |
| Q4 2021 | 2021-04-30 | $24.8M | $7.3M | +41.70% |
| Q3 2021 | 2021-01-31 | $15.4M | $1.2M | +8.75% |
| Q2 2021 | 2020-10-31 | $15.7M | $3.1M | +24.71% |
| Q1 2021 | 2020-07-31 | $17.1M | $1.5M | +9.47% |
| Q4 2020 | 2020-04-30 | $17.5M | $4.2M | +31.92% |
| Q3 2020 | 2020-01-31 | $14.2M | −$67,000 | −0.47% |
| Q2 2020 | 2019-10-31 | $12.6M | −$1.4M | −10.08% |
| Q1 2020 | 2019-07-31 | $15.6M | $491,000 | +3.25% |
| Q4 2019 | 2019-04-30 | $13.3M | $2.4M | +22.27% |
| Q3 2019 | 2019-01-31 | $14.2M | $379,000 | +2.74% |
| Q2 2019 | 2018-10-31 | $14.0M | $164,000 | +1.19% |
| Q1 2019 | 2018-07-31 | $15.1M | $2.0M | +15.13% |
| Q4 2018 | 2018-04-30 | $10.9M | −$960,000 | −8.13% |
| Q3 2018 | 2018-01-31 | $13.9M | $3.1M | +28.84% |
| Q2 2018 | 2017-10-31 | $13.8M | $1.9M | +16.15% |
| Q1 2018 | 2017-07-31 | $13.1M | $1.8M | +16.12% |
| Q4 2017 | 2017-04-30 | $11.8M | −$2.8M | −18.89% |
| Q3 2017 | 2017-01-31 | $10.8M | −$3.1M | −22.40% |
| Q2 2017 | 2016-10-31 | $11.9M | −$491,000 | −3.96% |
| Q1 2017 | 2016-07-31 | $11.3M | $1.6M | +16.48% |
| Q4 2016 | 2016-04-30 | $14.6M | $2.5M | +20.85% |
| Q3 2016 | 2016-01-31 | $13.9M | −$1.1M | −7.48% |
| Q2 2016 | 2015-10-31 | $12.4M | −$1.7M | −12.05% |
| Q1 2016 | 2015-07-31 | $9.7M | $1.4M | +16.80% |
| Q4 2015 | 2015-04-30 | $12.1M | $4.5M | +59.16% |
| Q3 2015 | 2015-01-31 | $15.0M | $7.2M | +93.45% |
| Q2 2015 | 2014-10-31 | $14.1M | −$13.6M | −49.12% |
| Q1 2015 | 2014-07-31 | $8.3M | −$13.6M | −62.03% |
| Q4 2014 | 2014-04-30 | $7.6M | $5.0M | +194.94% |
| Q3 2014 | 2014-01-31 | $7.7M | −$10.2M | −56.92% |
| Q2 2014 | 2013-10-31 | $27.7M | $12.6M | +83.75% |
| Q1 2014 | 2013-07-31 | $21.9M | −$139,000 | −0.63% |
| Q4 2013 | 2013-04-30 | $2.6M | −$25.3M | −90.78% |
| Q3 2013 | 2013-01-31 | $18.0M | −$8.9M | −33.15% |
| Q2 2013 | 2012-10-31 | $15.1M | −$16.3M | −51.94% |
| Q1 2013 | 2012-07-31 | $22.0M | −$5.3M | −19.36% |
| Q4 2012 | 2012-04-30 | $27.8M | $2.1M | +8.12% |
| Q3 2012 | 2012-01-31 | $26.9M | — | — |
| Q2 2012 | 2011-10-31 | $31.4M | — | — |
| Q1 2012 | 2011-07-31 | $27.3M | — | — |
| Q4 2011 | 2011-04-30 | $25.8M | $225,000 | +0.88% |
| Q4 2010 | 2010-04-30 | $25.5M | — | — |
Amrep cash and equivalents trends
Over the last five fiscal years, Amrep's cash and equivalents increased from $24.8M to $52.3M, a change of $27.5M. The latest reported quarter, Q4 2026, shows $52.3M.
What cash and equivalents mean
Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.
Reported cash and equivalents
TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Amrep source filings ↗Community posts
AMREP reports steep decline in quarterly property revenue and profit
AMREP’s ($AXR) first-quarter fiscal 2027 revenue fell to $6.1 million from $17.9 million a year earlier. Net income dropped to $276,000 from $4.7 million, with earnings per share declining to $0.05 from $0.87. The figures show a sharp year- ...